The cGAS-STING pathway is important in microbial infection, autoimmune diseases, and cancer (Tao et al. 2016). DNA within the cytosol can be an indicator of pathogen invasion and is sensed by cyclic GMP-AMP synthase (cGAS). Mitochondrial DNA (mtDNA) can also serve as a cGAS ligand in a certain context (Ma et al. 2020). As an example, during apoptosis, the mtDNA escapes into the cytoplasm and binds cGAS (McArthur et al. 2018).
cGAS binds double-stranded DNA (dsDNA) in a sequence-independent manner, but with preference for long dsDNA (Luecke et al. 2017 and Ma et al. 2020). cGAS synthesizes cyclic dinucleotide GMP‐AMP (cGAMP) from GTP and ATP. cGAMP then binds stimulator of interferon genes (STING, also known as TMEM173) to initiate downstream signaling (Sun et al. 2013). Intracellular bacteria can secrete the cyclic-di-AMP, cyclic-di-GMP, and cyclic-GMP-AMP that also bind to STING. Moreover, cGAMP can be transferred from cells to cells through gap junctions (Ablasser et al. 2013) and through incorporation into virions (Bridgeman et al. 2015).
Upon binding, STING undergoes oligomerization and translocates from the endoplasmic reticulum (ER) to ER-Golgi compartments (Kwon and Bakhoum 2019). At the Golgi, STING is palmitoylated at Cys88/91 (Mukai et al. 2016). Further, the TANK-binding kinase 1 (TBK1) phosphorylates STING on Ser366 (Tao et al. 2016). The interferon regulatory factor 3 (IRF3) is also recruited to the signaling complex and phosphorylated by TBK1 (Liu et al. 2015). Phosphorylated IRF3 forms a homodimer and enters the nucleus to activate transcription from Type I IFNs, which are important for host protection.
Type I IFNs bind to interferon alpha/beta receptor 1 (IFNAR1) and interferon alpha/beta receptor 2 (IFNAR2) and activates Janus kinase 1 (JAK1) and tyrosine kinase 2 (TYK2). This results in phosphorylation of the signal transducers and activators of transcription (STATs). STAT1, STAT2, and interferon regulatory factor 9 (IRF9) translocates to nucleus and activates transcription of IFN target genes (Zhu et al. 2019) involved in host immune response. The cGAS-STING pathway can also activate NF-kB signaling leading to transcription of inflammatory cytokines. Therefore, activation of the cGAS-STING pathway leads to expression of various immunomodulatory genes and potent antimicrobial responses.
The effects of the cGAS-STING on cancer depend on various factors including the type of tumor, the immune status of the host, and the activated cell type. Positive regulation of the pathway is an attractive method to enhance the immune status, while negative regulation can control abnormal inflammation (Wan et al. 2020).
Therapies targeting this pathway look promising for being translated into clinical applications.
We have compiled key proteins involved in the cGAS-STING signaling pathway into one handy poster you can download for your reference.
Click the pathway components within the images below to discover the key antibodies that Bio-Rad provides.
Browse Bio-Rad’s range of antibodies against targets involved with the cGAS-STING pathway. Please use the filters to sort the attributes in the table below to find the antibody that meets your needs. If you need any further assistance, please do not hesitate to contact us.
Description | Target | Format | Clone | Applications | Citations | Code |
---|